Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
Cancers|December 24, 2021
Cancer Therapy Targeting CD47/SIRPαNazli Dizman, Elizabeth I Buchbinder
European Urology Focus|February 2, 2025
Beyond the Microbiome: The Role of the Metabolome and Diet in Antitumor ImmunityNazli Dizman, Margaux Robert, Jennifer McQuade
Hematology/Oncology Clinics of North America|March 24, 2021
Immune Checkpoint Therapies for MelanomaElizabeth I Buchbinder
Therapeutic Advances in Medical Oncology|June 9, 2022
Missing the trees for the forest: most subgroup analyses using forest plots at the ASCO annual meeting are inconclusiveAndrew W Hahn, Nazli Dizman, Pavlos Msaouel
European Urology|February 7, 2026
Contextualizing the Development of Anti-HER2 Therapies for Patients with Advanced Urothelial CarcinomaBrigida Anna Maiorano, Nazli Dizman, Andrea Necchi
Nature Reviews. Nephrology|June 21, 2020
Genomic profiling in renal cell carcinomaNazli Dizman, Errol J Philip, Sumanta K Pal
Cancer Cell|March 21, 2025
Of HIFs and hERVs: Neoantigen generation in kidney cancerNicholas J Salgia, Nazli Dizman, Sumanta K Pal
Urologic Oncology|October 18, 2017
Cytoreductive nephrectomy: A medical oncologist's perspectiveNazli Dizman, Manuel Caitano Maia, Sumanta K Pal
American Journal of Clinical Oncology|November 13, 2015
CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their InhibitionElizabeth I Buchbinder, Anupam Desai
American Journal of Clinical Dermatology|January 28, 2025
Individualized Neoantigen-Directed Melanoma TherapyKaram Khaddour, Elizabeth I Buchbinder
Pageof 15